title: Should methotrexate remain the first-line drug for psoriasis?
authors.affiliation: Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, Toronto, ON M5T 2S8, Canada. Electronic address: dafna.gladman@utoronto.ca.
authors.forename: Dafna D
authors.initials: DD
authors.lastname: Gladman
mesh_terms: D003879:Dermatologic Agents; D006801:Humans; D008727:Methotrexate; D011565:Psoriasis
chemical_list: D003879:Dermatologic Agents; D008727:Methotrexate